If this turns out to be true, IMO it's unconscionable for the FDA to make EPP patients wait another year just for a Phase III trial. Italy has already allowed EPP sufferers to have the drug. And given the excellent safety profile of the drug, this is the FDA being the same old FDA.
The FDA needs a massive overhaul (again).
I've always been confident the EMA would approve the drug for EPP. I can't express the same level of confidence with the FDA.
If this turns out to be true, IMO it's unconscionable for the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$10.86 |
Change
0.090(0.84%) |
Mkt cap ! $544.3M | |||
| Open | High | Low | Value | Volume |
| $10.60 | $10.86 | $10.54 | $732.3K | 68.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1776 | $10.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.95 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |